Future diagnostics - wim smit 24032011
-
Upload
radboud-universitair-medisch-centrum -
Category
Health & Medicine
-
view
979 -
download
2
description
Transcript of Future diagnostics - wim smit 24032011
![Page 1: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/1.jpg)
![Page 2: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/2.jpg)
Mission
Future Diagnostics intends to become the best developer for third parties of high‐quality and innovative diagnostic tests, today, and in the future, seen in the eyes of our customers and our employees.
![Page 3: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/3.jpg)
VisionFuture Diagnostics intends to become the market leader in test development for third parties
We want to become the independent partner of the top 25 IVD companies for their test development
We would like to achieve this position by translating new technologies and novel ‘Intellectual Properties’ to the development of innovative tests with the shortest possible development time at the lowest possible costs
![Page 4: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/4.jpg)
Facts
Founded May 01st, 1997
Privately owned
Current number of employees is 65
Current number of projects is 35 out of a maximum of 40
Highly qualified staff
ISO 9001/2000 and ISO 13485 compliant
FDA inspections in 2004 and 2008
![Page 5: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/5.jpg)
Objective
The development of diagnostic tests and technologies for third parties
We are able to carry out development projects on almost any platform
Antibody Screening
Feasibility
Optimization
Verification
Technical Validation
Clinical Validation
Pilot Production
Support in 510(k) filing and CE registration
![Page 6: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/6.jpg)
![Page 7: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/7.jpg)
Facilities
Total 3500 m2
( Lab: 2000 m2 )
Operational February 2011
![Page 8: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/8.jpg)
![Page 9: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/9.jpg)
Bone Fertility Cancer
Bioactive PTHCalcitoninCip and CapDPDIntact‐PTHPTHPTHrp1,25‐OH Vitamin D25‐OH Vitamin DVitamin D BP
AldosteroneAndrostendione11‐Desoxy‐cortisolDHEADHEA‐SDHTEstradiolEstriolFree testosteronehCGLH17‐OH ProgesteroneSHBGTestosterone
β‐2MEGFEGF receptorE2 receptorFree PSAIGF‐1IGFBP3P53Progesterone receptorPSA
> 120 developed assays
![Page 10: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/10.jpg)
Cardiovascular Endocrine Infectious disease
AngiotensinANPBNPCatecholaminesCK‐MBD‐DimerFactor VIIIFibrin‐monomerFibrinogenGalectin‐3HS‐CRPMyoglobinNT Pro‐BNPProtein‐CPro‐reninRenincTroponint‐PA‐PAI‐1uPA‐PAI‐1VasopressinvWF
ACTHAnti‐TgAnti‐TPOC‐peptideCorticosteronCortisolCortisonHbA1cFecal Occult BloodFree T3GastrinGHBPhGHIL‐2 receptorIL‐6InsulinMelatoninNewborn screeningThyroglobulin
Anti‐HBcAnti‐HBsCMV IgG+IgMEBVGonorrheaHBcTHBsAgHBsAg confirmativeHCVHIV AbHIV Ag+AbHIV‐1,2,”O”LymeRubella IgG+IgMSyphilisToxoplasmosis IgG+IgMTuberculosis
![Page 11: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/11.jpg)
IntraOperative Autoimmune
STAT‐ACTHSTAT‐C‐peptideSTAT‐InsulinSTAT‐Intact PTH
Anti‐Cardiolipin IgG+ IgMAnti‐GADAnti‐IA2Anti‐InsulinAnti‐SMSMultiplex auto antibodies
Anemia Drugs of Abuse Others
EPOFerritinFolateVitamin B12
AtrazineDESSalbutamol
cGMPCGRPCow Milk ProgesteroneFPAMAP2OpsinRhodopsinS100Tyrosine Kinase
![Page 12: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/12.jpg)
Our Customers
![Page 13: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/13.jpg)
Experience on many platformsImmuno analyzers
Chemistry analyzers
Other
![Page 14: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/14.jpg)
Partnerships
Intellectual Property Vitamin D
Intellectual Property HbA1c
![Page 15: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/15.jpg)
Experience in Technologies
Chemiluminescence
Bioluminescence
Fluorescence
Enzyme Based Immuno Assay
Colorimetric Assays
Turbidimetric Assays
DNA Assays
Point of Care
![Page 16: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/16.jpg)
How we make our lab yours?
Monthly Fee Royalties on sales
Balanced out = Shared Risk
![Page 17: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/17.jpg)
![Page 18: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/18.jpg)
Wie is mijn klant?
![Page 19: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/19.jpg)
Wie is mijn klant?
R&D of Business Development
![Page 20: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/20.jpg)
Wat voor businessmodel?
Fee of een royalty project?
![Page 21: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/21.jpg)
Wat voor businessmodel?
Fee of een royalty project?
Wat is bepalend voor deze keus??
![Page 22: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/22.jpg)
Hoe controleer ik mijn royalty inkomsten?
![Page 23: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/23.jpg)
Hoe controleer ik mijn royalty inkomsten?
Hoe is FDx er zeker van dat het minimaal haar gemaakte kosten
terugverdiend?
![Page 24: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/24.jpg)
Personeel
Hoe vang ik mijn piekbelasting op?
![Page 25: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/25.jpg)
Liquiditeit
Hoe blijf ik aan mijn kortlopende verplichtingen voldoen?
![Page 26: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/26.jpg)
![Page 27: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/27.jpg)
• Less than 5% of the $3 trillion spent each year on the health care worldwide is for clinical laboratory services.
• Considering that nearly 70% of health care decisions are based on critical diagnostics information, biomedical testing represents a significant source of value in healthcare.
Trends in healthcare
Source: TriMark Publications
![Page 28: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/28.jpg)
7/21/201128
![Page 29: Future diagnostics - wim smit 24032011](https://reader034.fdocuments.us/reader034/viewer/2022052618/548697e1b4af9fa00d8b527b/html5/thumbnails/29.jpg)
Thank you for your attention